DNA Replication Stress‐Induced Transcriptome of Human Burkitt's Lymphoma Identifies Reciprocal Regulation Between MBD1 and BCL6 During Germinal Center‐Derived B‐Lymphomagenesis
Hematological Oncology · 2026
DOI: 10.1002/hon.70227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematological Oncology, 2026. Verfasst von Santosh Kumar Gothwal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Frontier Science Initiative, Kanazawa University, Kanazawa, Japan. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-bcl-6, DNA-Binding Proteins, Burkitt Lymphoma, Germinal Center. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Institute for Basic Science, Association of Zoos and Aquariums.
Abstract (Originalsprache)
BCL6 is a master transcriptional regulator of germinal center (GC) B cells. BCL6 is frequently translocated at the major translocation cluster (MTC) within intron 1 of the BCL6 locus, a hotspot commonly rearranged in diffuse large B cell lymphomas (DLBCLs). BCL6 amplifications are associated with therapeutic resistance and poor survival outcomes in hematological and solid cancers. However the mechanisms suppressing genome instability at the BCL6 ‐MTC preventing BCL6 rearragements remain unclear. Here, transcriptome analysis and genome‐wide mapping of histone H3 lysine 4 trimethylation (H3K4me3) in hydroxyurea (HU)‐treated Raji cells (a Burkitt's lymphoma model) revealed the induced expression of MBD1, encoding the DNA CpG methylation‐binding protein. Functional studies using shRNA silencing and ectopic overexpression demonstrated that MBD1 suppresses BCL6 transcription whose promoter harbors conserved CpG methylation sites, suggesting a DNA methylation‐dependent regulation of BCL6 trasncription by MBD1. Conversely, BCL6 repressed MBD1 expression by binding to its promoter. MBD1 ‐depleted Raji cells exhibited increased genomic instability at the BCL6 ‐MTC upon HU treatment, heightened sensitivity to DNA replication inhibitors (HU, gemcitabine, and etoposide), and reduced tumorigenicity in xenograft mouse models. We propose that MBD1 prevents genomic instability at the BCL6 ‐MTC to suppress DLBCL formation. Moreover, MBD1 promotes genomic stability and cell viability during DNA replication stress. MBD1 thus represents a potential therapeutic target for cancers exhibiting resistance to chemotherapies targeting DNA replication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Frontier Science Initiative, Kanazawa University, Kanazawa, Japan.
- Center for Genomic Integrity, Institute for Basic Science, Daejeon, South Korea.
- Department of Biochemistry, Graduate School of Medicine, Tohoku University, Sendai, Japan.
- Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan, Korea.
- Department of Microbiology and Molecular Genetics, University of California Davis, Davis, California, USA.
ORCID-Profile: Santosh Kumar Gothwal
Förderung
- Japan Society for the Promotion of Science
- Institute for Basic Science
- Association of Zoos and Aquariums
Zitieren
APA
Gothwal, S. K., Oichai, K., Kim, H., Myung, K., & Barlow, J. H. (2026). DNA Replication Stress‐Induced Transcriptome of Human Burkitt's Lymphoma Identifies Reciprocal Regulation Between MBD1 and BCL6 During Germinal Center‐Derived B‐Lymphomagenesis. Hematological Oncology. https://doi.org/10.1002/hon.70227
Vancouver
Gothwal SK, Oichai K, Kim H, Myung K, Barlow JH. DNA Replication Stress‐Induced Transcriptome of Human Burkitt's Lymphoma Identifies Reciprocal Regulation Between MBD1 and BCL6 During Germinal Center‐Derived B‐Lymphomagenesis. Hematological Oncology. 2026. doi:10.1002/hon.70227
BibTeX
@article{Gothwal2026,
author = {Gothwal, Santosh Kumar and Oichai, Kyoko and Kim, Hongtae and Myung, Kyungjae and Barlow, Jacqueline H},
title = {DNA Replication Stress‐Induced Transcriptome of Human Burkitt's Lymphoma Identifies Reciprocal Regulation Between MBD1 and BCL6 During Germinal Center‐Derived B‐Lymphomagenesis},
journal = {Hematological Oncology},
year = {2026},
doi = {10.1002/hon.70227}
}
EUVIMED